<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105453</url>
  </required_header>
  <id_info>
    <org_study_id>2016/220</org_study_id>
    <nct_id>NCT03105453</nct_id>
  </id_info>
  <brief_title>The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)</brief_title>
  <official_title>The Microbiome in Subfertility and Assisted Reproductive Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the impact of the female genital microbiome on ART outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to learn more about which microbial spectra are
      negatively or positively impacting IVF pregnancy outcome. This information is needed before
      proceeding to the next step in which an adaptation of the microbiome can be attempted to
      improve IVF outcome. The study is expected to shed light over the possible influence of the
      microbiome on causes for subfertility, endometrial receptivity and obstetrical complications.
      A diagnostic link may be found with entities that are often unexplained today, e.g.
      (recurrent) miscarriage and repeated implantation failure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>7 weeks</time_frame>
    <description>To determine if there Is there a association between the microbiome profile and pregnancy outcome after ART</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline microbiome profile</measure>
    <time_frame>1 week</time_frame>
    <description>Descriptive analysis of the microbiome present in women suffering of infertility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Variation of microbiome profile during assisted reproductive technologies</measure>
    <time_frame>5 weeks</time_frame>
    <description>Descriptive analysis of the microbiome present in women suffering of infertility according to the assisted reproductive technologies cycle stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiome profile of the embryo culture</measure>
    <time_frame>1 week</time_frame>
    <description>Descriptive analysis of the microbiome present in the embryo culture on the day of embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth</measure>
    <time_frame>43 weeks</time_frame>
    <description>To determine if there Is there a association between the microbiome profile and pregnancy outcome after assisted reproductive technologies</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infertility</condition>
  <condition>Subfertility</condition>
  <arm_group>
    <arm_group_label>Study arm</arm_group_label>
    <description>Women in the study arm will undergo microbiome samplings described in the interventions section (3 sampling points)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3 Sampling points</intervention_name>
    <description>When entering the in-vitro fertilization/intracytoplasmatic sperm injection 4 samples will be harvested: a rectal swab, a cervical swab, a vaginal swab and an intra-uterine sample using an empty embryo catheter. After the ovarian stimulation treatment, the same patients will be sampled two more times: once at the moment of oocyte retrieval (rectal, cervical, vaginal and intra-uterine samples) and again just before the embryo transfer (at this stage, the embryo culture medium will be harvested, as well as an intra-uterine sample using the tip of an empty embryo inner catheter before the embryo transfer and a rectal sample)</description>
    <arm_group_label>Study arm</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Microbiome analysis using 16S ribosomal RNA sequencing
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing in-vitro fertilization
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Caucasian women

          2. Women undergoing an in-vitro fertilization cycle (for the first or second time)

          3. Single embryo transfer

          4. Day 5 embryo transfer

          5. Gonadotropin-releasing hormone antagonist

          6. Anti-mullerian hormone &gt; 0,69 and &lt; 3,5 µg/L

          7. Body mass index ≤ 30 kg/m2

          8. Signed informed consent

        Exclusion Criteria:

          1. Women suffering of chronic diseases which may impair pregnancy outcome (e.g. diabetes,
             chronic renal disease).

          2. Antibiotics within 3 weeks of sampling

          3. Surgical sperm retrieval

          4. In-vitro maturation

          5. Preimplantation genetic diagnosis

          6. Grade 3 or 4 endometriosis

          7. Patients unable to comprehend the investigational nature of the proposed study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Blockeel, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Clinical head</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie Bussche, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research collaborator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christophe Blockeel, PhD</last_name>
    <phone>+3224776699</phone>
    <email>christophe.blockeel@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Bussche, Msc</last_name>
    <phone>+3224776699</phone>
    <email>julie.bussche@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Blockeel, PhD</last_name>
      <phone>+3224776699</phone>
      <email>christophe.blockeel@uzbrussel.be</email>
    </contact>
    <contact_backup>
      <last_name>Julie Bussche, Msc</last_name>
      <phone>+3224776699</phone>
      <email>julie.bussche@uzbrussel.be</email>
    </contact_backup>
    <investigator>
      <last_name>Shari Mackens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel Santos-Ribeiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Bussche, Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annalisa Racca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.brusselsivf.be/</url>
    <description>Principal research site</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Christophe Blockeel</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Assisted reproductive technologies</keyword>
  <keyword>Microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

